-
-
-
-
-
-
-
JPMorgan Upgrades CAMP4 Therapeutics Corp (CAMP) to Overweight
-
-
-
-
-
-
-
CAMP4 partners with GSK on RNA therapeutics for $17.5 million upfront
-
-
-
-
-
-
-
Calamp Corp. (CAMP) Reports Q2 Loss of $0.62
-
-
-
-
-
-
-
JPMorgan Starts CAMP4 Therapeutics Corp (CAMP) at Overweight
-
-
-
-
482,462 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


